- Canadian provinces Ontario and Quebec will pay for Abbott's (NYSE:ABT) FreeStyle Libre sensor-based glucose monitoring system for insulin-using residents at least 18 years old who are eligible for reimbursement under public programs.
- Health Canada approved the device in 2017.
Two Canada provinces on board with Abbott's FreeStyle Libre
Recommended For You
About ABT Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
ABT | - | - |
Abbott Laboratories |